Mathys & Squire v Astellas Institute for Regenerative Medicine (CFI, 4 November 2024)
| Date | 4 November 2024 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Central Division - Section |
| Type of action | Application RoP262.3 |
| Registry reference | App_54214/2024 · ORD_55220/2024 |
| Parties | Mathys & Squire LLP |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 4 November 2024 (UPC_CFI_75/2023, ACT_464985/2023), the Munich Central Division (U. Voß, presiding, A. Kupecz, rapporteur, and P. Gerli, technically qualified judge), in the revocation action against EP 3 056 563 brought by Astellas Institute for Regenerative Medicine against Healios, Riken and Osaka University, granted Mathys & Squire, a non-party, access to the unredacted version of two pleadings (Reply of 29 November 2023 and Rejoinder of 29 December 2023). The order shows that redactions not justified in good time will not withstand an access request from a member of the public.
Question
Should information redacted by the claimant, concerning its product pipeline timeline and filed in support of its position on the value of the dispute, remain confidential vis-à-vis the third party seeking access?
Decision
Access to the pleadings had been granted on 22 August 2024 under Rule 262.1(b), but only redacted versions of the two documents were released. The application meets the formal requirements of Rule 262.4 and is admissible. Following the Court of Appeal in Ocado v Autostore, the Court weighs the applicant’s interest in access only against the party’s legitimate interest in confidentiality. Once the applicant credibly sets out its reasons, the party claiming confidentiality must rebut them with substantiation, an approach the Court applies by analogy with a Court of Appeal order on security for costs. The claimant did not show that the information remained confidential and, invited to comment by the preliminary order of 8 October 2024, added nothing, the defendants did not respond. The balance favours the third party, and the Registry is instructed to release the full versions.
Key points for practice
- Practical point: a party redacting information must substantiate its confidentiality when a third party seeks access, otherwise the full version will be released.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 45
- Rules of Procedure
- Rules 262.1(b), 262.2, 262.3, 262.4, 262.5 and 262.6
- Case law cited
- Ocado Innovation v Autostore, Court of Appeal, 10 April 2024, Court of Appeal, 17 September 2024, UPC_CoA_217/2024 (security for costs), Astellas v Healios, Munich Central Division, 22 August 2024.
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Confidentiality club.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantMathys & Squire LLP2 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application RoP262.3
- Outcome (Dhenne Avocats summary)
- Mathys & Squire obtient l'accès à la version non occultée de deux écritures, la demanderesse n'ayant pas étayé le caractère confidentiel des informations occultées.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 056 563mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) cited in this record
- Ocado Innovation v Autostore (CoA, 10 April 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 056 563Method of producing retinal pigment epithelial cell recorded proprietor: Healios KK, RIKEN et University of Osaka NUC | Mentioned in the analysis (role not qualified) Also mentioned in 7 other decision(s): Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 Au · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 23 Ju · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 M · Mathys & Squire v Astellas (CFI, 28 December 2023) · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_C · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 Se · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_ | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.